Opioid Wizard for Opioid Use Disorder (OUD)

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Opioid Use Disorder (OUD)+2 More
Opioid Wizard - Other
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will develop and implement a web-based and electronic health record-integrated Opioid Use Disorder Clinical Decision Support system to offer expert guidance to primary care providers on the diagnosis and management of Opioid Use Disorder.

Eligible Conditions
  • Opioid Use Disorder (OUD)

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Opioid Use Disorder (OUD)

Study Objectives

4 Primary · 5 Secondary · Reporting Duration: This will be calculated at the end of the study, approximately month 53

Month 53
Calculate differences in average days covered by MOUD prescription
Calculate differences in rate of MOUD orders or referrals
Calculate differences in rate of naloxone rescue kit ordering
Calculate differences in rates of OUD diagnosis
Comparing all-cause mortality rates between intervention and control clinic patients
Comparing rates of fatal and non-fatal overdoses between intervention and control clinic patients
Difference between number of Emergency Department visits for intervention and control patients
Differences in the number of hospitalizations for intervention and control patients
Intervention patients will have lower healthcare compared to patients from usual care clinics

Trial Safety

Safety Progress

1 of 3

Other trials for Opioid Use Disorder (OUD)

Trial Design

2 Treatment Groups

Does not Receive the OUD-CDS
1 of 2
Receives OUD-CDS
1 of 2
Active Control
Experimental Treatment

3600000 Total Participants · 2 Treatment Groups

Primary Treatment: Opioid Wizard · No Placebo Group · N/A

Receives OUD-CDS
Other
Experimental Group · 1 Intervention: Opioid Wizard · Intervention Types: Other
Does not Receive the OUD-CDSNoIntervention Group · 1 Intervention: Does not Receive the OUD-CDS · Intervention Types:

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: this will be calculated at the end of the study, approximately month 53

Who is running the clinical trial?

Geisinger ClinicOTHER
134 Previous Clinical Trials
1,322,873 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,225 Previous Clinical Trials
2,012,927 Total Patients Enrolled
130 Trials studying Opioid Use Disorder (OUD)
1,080,292 Patients Enrolled for Opioid Use Disorder (OUD)
The Emmes Company, LLCIndustry Sponsor
135 Previous Clinical Trials
1,039,514 Total Patients Enrolled
8 Trials studying Opioid Use Disorder (OUD)
981,695 Patients Enrolled for Opioid Use Disorder (OUD)
Hennepin Healthcare Research InstituteOTHER
84 Previous Clinical Trials
64,691 Total Patients Enrolled
3 Trials studying Opioid Use Disorder (OUD)
279 Patients Enrolled for Opioid Use Disorder (OUD)
Essentia HealthOTHER
26 Previous Clinical Trials
97,420 Total Patients Enrolled
HealthPartners InstituteLead Sponsor
166 Previous Clinical Trials
1,307,035 Total Patients Enrolled
3 Trials studying Opioid Use Disorder (OUD)
279 Patients Enrolled for Opioid Use Disorder (OUD)

Eligibility Criteria

Age 18+ · All Participants · 3 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are aged 18-75 years, inclusive, at the time of an index visit.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 10th, 2021

Last Reviewed: October 21st, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.